U.S. Stock News

NYSE:ESE
NYSE:ESEMachinery

ESCO Technologies (ESE) Could Be 21% Below Fair Value On Raised 2026 Guidance

ESCO Technologies (ESE) drew fresh attention after reporting third quarter sales of $339.03 million and net income of $32.74 million, along with higher full year revenue and earnings guidance for 2026. See our latest analysis for ESCO Technologies. At a share price of $305.86, ESCO Technologies has seen strong momentum, with a year to date share price return of 54.77% and a 1 year total shareholder return of 65.35%, building on a very large 3 year total shareholder return. If this kind of...
NYSE:NMAX
NYSE:NMAXMedia

Newsmax (NMAX) Turned Profitable, Is The Stock Still Cheap?

Newsmax (NMAX) stock is in focus after the company reported its first profitable quarter as a public company and reiterated full year 2026 revenue guidance of US$212 million to US$216 million. See our latest analysis for Newsmax. The earnings and guidance update has coincided with a sharp shift in sentiment toward Newsmax, with the share price at US$10.87 after a 1-day share price return of 14.54% and a 90-day share price return of 50.55%. However, the 1-year total shareholder return is down...
NasdaqCM:ASLE
NasdaqCM:ASLEAerospace & Defense

Aviation Safety Stocks Getting A Fresh Look After The Air India A320 Scare

The Air India A320 scare and reports of pilot drug testing have pushed aviation safety and compliance back into the spotlight, and that ripple can reach far beyond one airline. When regulators tighten rules and airlines rush to prove their standards, companies tied to testing, certification, and risk management can gain fresh attention. This article unpacks three stocks exposed to this news and explains why their role in safety could matter for your portfolio. The three stocks highlighted...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Natera (NTRA) Lands Kupando Trial Deal, Is The Upside Already Priced In?

Natera (NTRA) is back in focus after agreeing to supply its Latitude molecular residual disease test for Kupando Therapeutics’ Phase 1 trial of lead immunotherapy KUP-101 in advanced skin cancers. See our latest analysis for Natera. The Kupando trial agreement comes after a very strong run in Natera’s stock, with a 30 day share price return of 14.2% and a 90 day share price return of 60.97%. The 1 year total shareholder return of 90.12% and very large 3 year total shareholder return suggest...
NYSE:VZ
NYSE:VZTelecom

Does Verizon’s Pixel 11 Push and AI Partnerships Reshape the Bull Case For Verizon Communications (VZ)?

In early August 2026, Verizon Communications rolled out an extensive Google Pixel 11 lineup and Pixel Watch 5 offering on its Simplicity and business plans, alongside aggressive device, trade-in, bundling and accessory promotions, while also expanding Verizon Family app capabilities with Fi’s pet-tracking integration. At the same time, Verizon raised long-dated, variable-rate subordinated debt in the billions and deepened its technology partnerships across AI, 5G connectivity and safety...
NYSE:MIR
NYSE:MIRElectronic

Should Mirion’s DOE Cleanup Partnership With Perma-Fix Under SBA Program Require Action From Mirion (MIR) Investors?

Perma-Fix Environmental Services announced in August 2026 that it had formed a Partnership with Mirion Technologies under the SBA’s Mentor-Protégé Program to jointly pursue U.S. Department of Energy nuclear cleanup and environmental remediation work. The collaboration pairs Perma-Fix’s nuclear waste treatment and remediation capabilities with Mirion’s radiation detection and measurement technologies, potentially enhancing their competitiveness in complex, long-duration federal cleanup...
NYSE:MRP
NYSE:MRPSpecialized REITs

Is Millrose Properties (MRP) Undervalued Following Its Lower Interest Rate Credit Agreement?

What the latest credit agreement change means for Millrose Properties stock Millrose Properties (MRP) recently amended its credit agreement with lenders, reducing the interest rate on its loans by 0.25% per year. This financing move gives investors fresh information on the company’s funding costs. See our latest analysis for Millrose Properties. The interest savings come on the heels of Millrose Properties’ second quarter earnings release on 4 August 2026, which gave investors fresh detail on...
NYSE:PL
NYSE:PLProfessional Services

What Is Drawing Fresh Attention To Planet Labs PBC (PL)?

Planet Labs PBC (PL) is back in focus after announcing a national satellite data program with the Government of Rwanda, giving multiple public agencies, universities, and startups access to its near-daily Earth imagery. See our latest analysis for Planet Labs PBC. The Rwanda program lands at a time when Planet Labs PBC’s short-term share price momentum is rebuilding, with a 30-day share price return of 9.88%, even though the 90-day share price return is down 40.66%. Over a longer horizon,...
NYSE:GLOB
NYSE:GLOBIT

Can Globant (NYSE:GLOB) Earn Back Investor Trust At This Price?

Globant stock is coming off a very weak run, with the share price sharply lower over the past five years, yet the valuation checks currently lean cheap. With fresh attention on its AI offerings and fan engagement work with FIFA, investors are weighing a poor share price track record against a more positive read from the valuation metrics. Over the past five years Globant shareholders have seen the stock decline 87.4%, which sets a low bar for any potential recovery case. New AI initiatives...
NasdaqGS:FANG
NasdaqGS:FANGOil and Gas

Why Diamondback Energy (FANG) Is Up 7.7% After Earnings Beat, Guidance Hike And Dividend Boost

Diamondback Energy, Inc. reported past second-quarter 2026 results showing higher oil, gas and NGL production, revenue of US$5,562 million, net income of US$1,882 million, and declared a US$1.10 per-share cash dividend payable on August 20, 2026. The company also raised its full-year 2026 production guidance and continued its multi-year share repurchase program, having bought back 42,993,981 shares for about US$6.13 billion since 2021. We’ll now examine how Diamondback’s stronger quarterly...
NYSE:ACHR
NYSE:ACHRAerospace & Defense

Archer Aviation (ACHR) Is Up 18.4% After AI Breakthrough In Aircraft Trajectory Prediction Technology

In the second quarter of 2026, Archer Aviation reported US$5.0 million in sales and a net loss of US$263.2 million, while also announcing progress on its Midnight eVTOL operations and AI initiatives. Beyond the headline earnings, Archer’s ZEE aviation foundation model achieved a technical breakthrough in predicting real-time aircraft trajectories on airport surfaces, reinforcing its push into safety-focused aviation software alongside hardware development. We’ll now examine how ZEE’s...
NasdaqGS:APA
NasdaqGS:APAOil and Gas

APA (APA) Raises 2026 Oil Guidance, Is The Stock Still A Bargain?

APA (APA) is back in focus after raising its full year 2026 oil production guidance to 123,000 barrels per day, up from 120,000. The company also reported higher second quarter net income despite lower revenue. See our latest analysis for APA. APA’s raised 2026 oil production guidance and stronger Q2 profitability have arrived alongside strong price momentum, with a 14.91% 1 month share price return and a 59.58% year to date share price return. Over a longer horizon, the 1 year total...
NYSE:EG
NYSE:EGInsurance

Everest Group (EG) Stock May Be Cheap On Mexico Unit Sale

Everest Group has delivered a 51.7% total return over the past five years, yet the share price recently eased back and the valuation checks still suggest the stock leans cheap rather than stretched. Over five years, a 51.7% return points to shareholder value creation that now has investors asking whether the current price still offers a margin of safety. The planned sale of Everest Group's Mexico insurance operations to Fairfax can help sharpen the focus on core reinsurance and wholesale...
NYSE:MO
NYSE:MOTobacco

Is Altria Group (MO) A Bargain Following Smoke Free Growth And Pricing Gains?

Altria Group (MO) is drawing fresh attention as growth in smoke free products and disciplined pricing help offset weaker cigarette volumes and a softer oral tobacco segment. See our latest analysis for Altria Group. Altria Group’s share price has eased in recent weeks, with a 30 day share price return down 11.47% and a 90 day return down 10.88%. However, the year to date share price return of 14.64% and a 5 year total shareholder return of 99.49% show that long term holders have still seen...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Harmony Biosciences Holdings (HRMY), Why Is It Getting Fresh Attention?

Harmony Biosciences Holdings (HRMY) is drawing attention after reporting second quarter 2026 net income of US$75.43 million, along with record results for WAKIX and updates across several late stage neurology programs. See our latest analysis for Harmony Biosciences Holdings. The recent second quarter results and late stage pipeline updates come after a solid run for Harmony Biosciences Holdings, with a 30 day share price return of 12.88% and a 90 day share price return of 27.79%. Over a...
OTCPK:DIDI.Y
OTCPK:DIDI.YTransportation

DiDi Global (DIDI.Y) Is Up 13.6% After Posting a Quarterly Profit Despite First-Half Loss

In August 2026, DiDi Global Inc. reported second-quarter 2026 results, with sales of CNY 62,522 million and net income of CNY 866 million, compared with sales of CNY 56,404 million and a net loss of CNY 2,485 million a year earlier. The swing from loss to profit in the quarter contrasted with a loss over the first half of 2026, highlighting that recent operational performance has differed from the broader year-to-date picture. We will now explore how DiDi’s move to quarterly profitability,...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Raises 2026 Revenue Guidance, Is The Stock Still A Bargain?

Eli Lilly (LLY) just raised its 2026 revenue guidance to a range of US$85b to US$87b, up from US$82b to US$85b. The company paired this outlook update with detailed second quarter earnings. See our latest analysis for Eli Lilly. Eli Lilly's latest guidance and earnings sit against a backdrop of strong recent momentum, with the share price up 19.44% over 90 days and a year-to-date share price return of 9.24%, while the 1-year total shareholder return is 69.36%. If you are looking beyond Eli...
NasdaqGS:BBIO
NasdaqGS:BBIOBiotechs

Is BridgeBio Pharma (BBIO) Priced For Perfection Or Fair Value?

BridgeBio Pharma has delivered a strong share price run over the past three years, yet the broader valuation checks now point to a stock that looks closer to fairly priced than clearly cheap or clearly expensive. BridgeBio Pharma has returned 178.1% over the past three years, which sets a high bar for any further upside to be justified by fundamentals. Regulatory progress on rare disease therapies and recent capital raises can support expectations for future revenue growth, while the need to...
NasdaqGS:UAL
NasdaqGS:UALAirlines

United Airlines Holdings (UAL) Could Be 23% Undervalued On Fleet Upgrade Hopes

United Airlines Holdings (UAL) has drawn fresh attention after its stock gained about 8.6% over the past month and about 35% over the past 3 months, highlighting shifting sentiment around the company. See our latest analysis for United Airlines Holdings. Looking beyond the recent rally, United Airlines Holdings has had a mixed short term patch with the share price down 3.3% over the past week. At the same time, a 35.4% 3 month share price return and a 24.2% 1 year total shareholder return...
NasdaqGS:NXT
NasdaqGS:NXTElectrical

Solar Stocks Facing Tariff Pressure With U.S. Supply Chains In Focus

Solar stocks are suddenly at the center of a trade crackdown story, as U.S. officials scrutinize complex import routes and talk tough on tariff enforcement. That creates both potential winners and companies facing new headwinds, and investors who ignore it risk missing meaningful shifts in sentiment and pricing power. This article walks through 3 U.S.-listed solar project developers and installers that appear especially exposed to this trade shock narrative. The three solar stocks covered...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

How Softer Earnings and a Deeper Mastercard Alliance Could Reframe Fiserv’s (FISV) Investment Story

In early August 2026, Fiserv reported weaker second-quarter results, with revenue easing to US$5,292 million and net income falling to US$627 million compared with a year earlier, while earnings per share from continuing operations declined to US$1.17. At the same time, Fiserv moved to reshape its business through new partnerships with Mastercard and Stuut Technologies, a joint venture that formed MoneyPass Group, further client wins such as UW Credit Union, and continued share repurchases...
NYSEAM:SEB
NYSEAM:SEBFood

Seaboard (SEB) Reports Higher Earnings And Dividend, Is The Valuation Gap Justified?

Seaboard (SEB) drew fresh attention after reporting second quarter results that showed higher revenue, net income and earnings per share compared with a year earlier, along with a declared quarterly cash dividend of $2.25 per share. See our latest analysis for Seaboard. Seaboard's latest earnings and dividend news come as the share price has risen 2.6% in the last day but is down 6.2% over 90 days, while the 1 year total shareholder return of 23.1% points to stronger longer term momentum. If...
NasdaqGS:WBTN
NasdaqGS:WBTNInteractive Media and Services

Does WEBTOON Entertainment (WBTN) Look Fairly Valued After Its 45% Fall?

WEBTOON Entertainment stock has fallen sharply over the past year, yet the latest valuation checks suggest the shares now sit closer to fair value rather than looking clearly cheap or clearly expensive. The share price is down 44.7% over the past year, which means anyone buying today is looking at a stock that has already reset materially. The recent agreement to take a 60% stake in RI Games Holdings can support growth in game adaptations of WEBTOON content. However, any execution issues or...
NasdaqGS:CDW
NasdaqGS:CDWElectronic

The Bull Case For CDW (CDW) Could Change Following AI-Driven Earnings Beat And CFO Succession Plan

CDW Corporation reported that Chief Financial Officer Albert J. Miralles plans to retire in 2027, with a phased transition to an Executive Advisor role through March 31, 2028, while also announcing second-quarter 2026 sales of US$6,572.2 million and net income of US$274.4 million, alongside a quarterly dividend of US$0.630 per share. The combination of better-than-expected earnings tied to strong AI and modernization demand and a carefully staged CFO succession plan highlights CDW’s focus on...